151 related articles for article (PubMed ID: 16081686)
1. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.
Tome ME; Johnson DB; Rimsza LM; Roberts RA; Grogan TM; Miller TP; Oberley LW; Briehl MM
Blood; 2005 Nov; 106(10):3594-601. PubMed ID: 16081686
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract][Full Text] [Related]
3. Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma.
Ando T; Suguro M; Hanai T; Kobayashi T; Honda H; Seto M
Jpn J Cancer Res; 2002 Nov; 93(11):1207-12. PubMed ID: 12460461
[TBL] [Abstract][Full Text] [Related]
4. Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling.
Ando T; Suguro M; Kobayashi T; Seto M; Honda H
Cancer Sci; 2003 Oct; 94(10):906-13. PubMed ID: 14556665
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma.
Peroja P; Pasanen AK; Haapasaari KM; Jantunen E; Soini Y; Turpeenniemi-Hujanen T; Bloigu R; Lilja L; Kuittinen O; Karihtala P
Exp Hematol Oncol; 2012 Mar; 1(1):2. PubMed ID: 23210982
[TBL] [Abstract][Full Text] [Related]
6. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.
Caro P; Kishan AU; Norberg E; Stanley IA; Chapuy B; Ficarro SB; Polak K; Tondera D; Gounarides J; Yin H; Zhou F; Green MR; Chen L; Monti S; Marto JA; Shipp MA; Danial NN
Cancer Cell; 2012 Oct; 22(4):547-60. PubMed ID: 23079663
[TBL] [Abstract][Full Text] [Related]
7. The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.
Deng J; Pan T; Liu Z; McCarthy C; Vicencio JM; Cao L; Alfano G; Suwaidan AA; Yin M; Beatson R; Ng T
Br J Cancer; 2023 Dec; 129(12):1877-1892. PubMed ID: 37794178
[TBL] [Abstract][Full Text] [Related]
8. TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding.
Lim TY; Wilde BR; Thomas ML; Murphy KE; Vahrenkamp JM; Conway ME; Varley KE; Gertz J; Ayer DE
PLoS Biol; 2023 Mar; 21(3):e3001778. PubMed ID: 36930677
[TBL] [Abstract][Full Text] [Related]
9. Essential Roles of Peroxiredoxin IV in Inflammation and Cancer.
Thapa P; Ding N; Hao Y; Alshahrani A; Jiang H; Wei Q
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235049
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37.
Peeters R; Cuenca-Escalona J; Zaal EA; Hoekstra AT; Balvert ACG; Vidal-Manrique M; Blomberg N; van Deventer SJ; Stienstra R; Jellusova J; Giera M; Hannibal L; Spiekerkoetter U; Ter Beest M; Berkers CR; van Spriel AB
Nat Commun; 2022 Sep; 13(1):5371. PubMed ID: 36100608
[TBL] [Abstract][Full Text] [Related]
11. ITCH facilitates proteasomal degradation of TXNIP in hypoxia- induced lung cancer cells.
Sun Q; Wang BB; Wei W; Huang GC; Liu LL; Chen WW; Wang J; Zhao XY; Lu L; Fang R; Zhu CY; Chu XY
Thorac Cancer; 2022 Aug; 13(15):2235-2247. PubMed ID: 35811256
[TBL] [Abstract][Full Text] [Related]
12. Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.
Liang XJ; Song XY; Wu JL; Liu D; Lin BY; Zhou HS; Wang L
Int J Biol Sci; 2022; 18(4):1313-1327. PubMed ID: 35280688
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-Interacting Protein in Cancer and Diabetes.
Masutani H
Antioxid Redox Signal; 2022 May; 36(13-15):1001-1022. PubMed ID: 34384271
[No Abstract] [Full Text] [Related]
14. Low expression of the PPARγ-regulated gene thioredoxin-interacting protein accompanies human melanoma progression and promotes experimental lung metastases.
Meylan P; Pich C; Winkler C; Ginster S; Mury L; Sgandurra M; Dreos R; Frederick DT; Hammond M; Boland GM; Michalik L
Sci Rep; 2021 Apr; 11(1):7847. PubMed ID: 33846376
[TBL] [Abstract][Full Text] [Related]
15. Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies.
Rodríguez-García A; García-Vicente R; Morales ML; Ortiz-Ruiz A; Martínez-López J; Linares M
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33271863
[TBL] [Abstract][Full Text] [Related]
16. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies.
Jaganjac M; Milkovic L; Sunjic SB; Zarkovic N
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33228209
[TBL] [Abstract][Full Text] [Related]
17. cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.
Domka K; Goral A; Firczuk M
Front Immunol; 2020; 11():1538. PubMed ID: 32793211
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis.
Estep RD; Govindan AN; Manoharan M; Li H; Fei SS; Park BS; Axthelm MK; Wong SW
PLoS One; 2020; 15(2):e0228484. PubMed ID: 32017809
[TBL] [Abstract][Full Text] [Related]
19. Both Ser361 phosphorylation and the C-arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint.
Kamitori K; Yamaguchi F; Dong Y; Hossain A; Katagi A; Noguchi C; Hirata Y; Tsukamoto I; Hatano N; Tokuda M
FEBS Open Bio; 2018 Nov; 8(11):1804-1819. PubMed ID: 30410860
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition.
Zhang B; Lyu J; Liu Y; Wu C; Yang EJ; Pardeshi L; Tan K; Wong KH; Chen Q; Xu X; Deng CX; Shim JS
Oncogene; 2018 Dec; 37(49):6341-6356. PubMed ID: 30042414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
